Clinicopathologic Features of IDH2 R172-Mutated Myeloid Neoplasms.

Adam R DavisBriana C CanadyNidhi Aggarwal Nathanael Glen Bailey

Published in: American journal of clinical pathology (2023)

We show that MNs with mR172 represent a morphologically and phenotypically distinct subtype, which in our cohort exhibited relatively favorable survival that is not captured in current AML risk assignment.

Keyphrases

acute myeloid leukemia
wild type
dendritic cells
bone marrow
low grade
magnetic resonance
contrast enhanced
allogeneic hematopoietic stem cell transplantation
immune response
acute lymphoblastic leukemia